Vyhodnocení PET nálezů na plicích u pacientů léčených pro Hodgkinský lymfom

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023884%3A_____%2F06%3A00000002" target="_blank" >RIV/00023884:_____/06:00000002 - isvavai.cz</a>

Výsledek na webu

—

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

PET finfings in the lungs of patients treated for Hodgkin disease

Popis výsledku v původním jazyce

The aim of this retrospective study was to evaluate FDG-PET findings in the lungs of patients with Hodgkin lymphoma.16 of the 22 patients included in the study had a negative PET finding after the first course of chemotherapy, i.e. they were considered to be in a complete remission of the disease. PET and HRCT revealed postradiation pneumonitis in two patients. In two patients a progression appeared after the first course of chemotherapy, in accordance with PET findings the progression was outside the lungs. In other two patients a persistence of lung involvement was observed on PET after the initial chemotherapy. These patients are without any relaps. One of them underwent lung biopsy which confirmed postchemotherapeutic changes. Positive FDG-PET findings in the lung parenchyma are quite frequent after the initial chemotherapy in patients with Hodgkin lymphoma with initial involvement of the lungs (4/22), the majority is represented by benign postchemotherapeutic and postradiation cha

Název v anglickém jazyce

PET finfings in the lungs of patients treated for Hodgkin disease

Popis výsledku anglicky

The aim of this retrospective study was to evaluate FDG-PET findings in the lungs of patients with Hodgkin lymphoma.16 of the 22 patients included in the study had a negative PET finding after the first course of chemotherapy, i.e. they were considered to be in a complete remission of the disease. PET and HRCT revealed postradiation pneumonitis in two patients. In two patients a progression appeared after the first course of chemotherapy, in accordance with PET findings the progression was outside the lungs. In other two patients a persistence of lung involvement was observed on PET after the initial chemotherapy. These patients are without any relaps. One of them underwent lung biopsy which confirmed postchemotherapeutic changes. Positive FDG-PET findings in the lung parenchyma are quite frequent after the initial chemotherapy in patients with Hodgkin lymphoma with initial involvement of the lungs (4/22), the majority is represented by benign postchemotherapeutic and postradiation cha

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FD - Onkologie a hematologie

OECD FORD obor

—

Projekt

<a href="/cs/project/NR8033" target="_blank" >NR8033: Redukce toxicity primární léčby pokročilého Hodgkinova lymfomu</a><br>

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2006

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

European Journal of Nuclear Medicine and Molecular Imaging

ISSN

1619-7070

e-ISSN

—

Svazek periodika

2006

Číslo periodika v rámci svazku

33

Stát vydavatele periodika

DE - Spolková republika Německo

Počet stran výsledku

1

Strana od-do

—

Kód UT WoS článku

—

EID výsledku v databázi Scopus

—